BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18809261)

  • 1. Prion and anti-codon usage: does infectious PrP alter tRNA abundance to induce misfolding of PrP?
    Rechavi O; Kloog Y
    Med Hypotheses; 2009 Feb; 72(2):193-5. PubMed ID: 18809261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.
    Tahiri-Alaoui A; James W
    Protein Sci; 2005 Apr; 14(4):942-7. PubMed ID: 15741327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible role of protein X, a putative auxiliary factor in pathological prion replication, in regulating a physiological endoproteolytic cleavage of cellular prion protein.
    Hachiya NS; Imagawa M; Kaneko K
    Med Hypotheses; 2007; 68(3):670-3. PubMed ID: 17008028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion agent diversity and species barrier.
    Béringue V; Vilotte JL; Laude H
    Vet Res; 2008; 39(4):47. PubMed ID: 18519020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free formation of misfolded prion protein with authentic prion infectivity.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15818-23. PubMed ID: 17030802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
    Lin Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of recombinant prions with compounds of therapeutical significance.
    Georgieva D; Schwark D; von Bergen M; Redecke L; Genov N; Betzel C
    Biochem Biophys Res Commun; 2006 Jun; 344(2):463-70. PubMed ID: 16630566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtyping of human cellular prion proteins and their differential solubility.
    Kuczius T; Wohlers J; Karch H; Groschup MH
    Exp Neurol; 2011 Jan; 227(1):188-94. PubMed ID: 21070768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel dominant-negative prion protein mutants identified from a randomized library.
    Ott D; Taraborrelli C; Aguzzi A
    Protein Eng Des Sel; 2008 Oct; 21(10):623-9. PubMed ID: 18676974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prions].
    Piasecki E
    Postepy Hig Med Dosw; 1993; 47(2):89-102. PubMed ID: 8415325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation and misfolding of PrP.
    Wiseman F; Cancellotti E; Manson J
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1094-5. PubMed ID: 16246053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
    J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deleted prion protein that is neurotoxic in vivo is localized normally in cultured cells.
    Christensen HM; Harris DA
    J Neurochem; 2009 Jan; 108(1):44-56. PubMed ID: 19046329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thr but Asn of the N-glycosylation sites of PrP is indispensable for its misfolding.
    Ikeda S; Kobayashi A; Kitamoto T
    Biochem Biophys Res Commun; 2008 May; 369(4):1195-8. PubMed ID: 18343219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.